Involvement of matrix metalloproteinase-9 in the development of morphine tolerance

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 86-92

  Nakamoto, Kazuo ^a   Kawasaki, Shintaro ^a   Kobori, Takuro ^a   Fujita Hamabe, Wakako ^a   Mizoguchi, Hiroyuki ^b   Yamada, Kiyofumi ^c   Nabeshima, Toshitaka ^d   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MEIJO UNIVERSITY   (Japan)

Author keywords

Matrix metalloproteinases 9; Morphine tolerance; Opioid

Indexed keywords

GELATINASE B; ILOMASTAT; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME MECHANISM; LATENT PERIOD; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TAIL FLICK TEST; TREATMENT DURATION; WILD TYPE; ZYMOGRAPHY;

ANALGESICS, OPIOID; ANIMALS; DIPEPTIDES; DRUG TOLERANCE; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; NERVE TISSUE PROTEINS; NEURONS; PAIN MEASUREMENT; PROTEASE INHIBITORS; SPINAL CORD; TIME FACTORS; UP-REGULATION;

EID: 84860466349     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.006     Document Type: Article

References (36)

1. H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, and A. DeCarlo Matrix metalloproteinases: a review Crit. Rev. Oral Biol. Med. 4 1993 197 250
2. G.J. del Zoppo, R. Milner, T. Mabuchi, S. Hung, X. Wang, G.I. Berg, and J.A. Koziol Microglial activation and matrix protease generation during focal cerebral ischemia Stroke 38 2007 646 651
3. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 3rd ed. 2007 Academic Press New York
4. J. Frässdorf, N.C. Weber, D. Obal, O. Toma, J. Müllenheim, G. Kojda, B. Preckel, and W. Schlack Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB Anesth. Analg. 101 2005 934 941
5. Y. Gasche, P.M. Soccal, M. Kanemitsu, and J.C. Copin Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain Front. Biosci. 11 2006 1289 1301
6. J.G. Gaudet, G.T. Yocum, S.S. Lee, A. Granat, M. Mikami, E.S. Connolly Jr., and E.J. Heyer MMP-9 levels in elderly patients with cognitive dysfunction after carotid surgery J. Clin. Neurosci. 17 2010 436 440
7. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br. J. Pharmacol. Chemother. 12 1957 12 15
8. Y.P. Han, C. Yan, L. Zhou, L. Qin, and H. Tsukamoto A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix J. Biol. Chem. 282 2007 12928 12939
9. S. Harada, W. Fujita-Hamabe, and S. Tokuyama Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage J Pharmaco Sci 115 2011 155 163
10. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur. J. Pharmacol. 67 1980 313 316
11. I.N. Johnston, E.D. Milligan, J. Wieseler-Frank, M.G. Frank, V. Zapata, J. Campisi, S. Langer, D. Martin, P. Green, M. Fleshner, L. Leinwand, S.F. Maier, and L.R. Watkins A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine J. Neurosci. 24 2004 7353 7365
12. E. Kalso, J.E. Edwards, R.A. Moore, and H.J. McQuay Opioids in chronic non-cancer pain: systematic review of efficacy and safety Pain 112 2004 372 380
13. Y. Kawasaki, Z.Z. Xu, X. Wang, J.Y. Park, Z.Y. Zhauang, P.H. Tan, Y.J. Gao, K. Roy, G. Corfas, E.H. Lo, and R.R. Ji Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain Nat. Med. 14 2008 331 336
14. J. Liu, J. Nickolenko, and F.R. Sharp Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors Proc. Natl. Acad. Sci. U.S.A. 91 1994 8537 8541
15. W.T. Liu, Y. Han, Y.P. Liu, A.A. Song, B. Barnes, and X.J. Song Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice J. Neurosci. 30 2010 7613 7623
16. J. Mao, D.D. Price, and D.J. Mayer Mechanisms of hyperalgesia and morphine-tolerance: a current view of their possible interactions Pain 62 1995 259 274
17. J. Mao, B. Sung, R.R. Ji, and G. Lim Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity J. Neurosci. 22 2002 8312 8323
18. L. Martini, and J.L. Whistler The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence Curr. Opin. Neurobiol. 17 2007 556 564
19. D.J. Mayer, J. Mao, J. Holt, and D.D. Price Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions Proc. Natl. Acad. Sci. U.S.A. 96 1999 7731 7736
20. J.I. McMillan, J.W. Riordan, W.G. Couser, A.S. Pollock, and D.H. Lovett Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy J. Clin. Invest. 97 1996 1094 1101
21. H. Mizoguchi, K. Yamada, A. Mouri, M. Niwa, T. Mizuno, Y. Noda, A. Nitta, S. Itohara, Y. Banno, and T. Nabeshima Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release J. Neurochem. 102 2007 1548 1560
22. S. Mun-Bryce, and G.A. Rosenberg Gelatinase B modulates selective opening of the blood-brain barrier during inflammation Am. J. Physiol. 274 1998 1203 1211
23. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J. Biol. Chem. 274 1999 21491 21494
24. W.C. Parks, C.L. Wilson, and Y.S. López-Boado Matrix metalloproteinases as modulators of inflammation and innate immunity Nat. Rev. Immunol. 4 2004 617 629
25. H.J. Ra, and W.C. Parks Control of matrix metalloproteinase catalytic activity Matrix Biol. 26 2007 587 596
26. F. Sellebjerg, and T.L. Sorensen Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system Brain Res. Bull. 61 2003 347 355
27. Y. Shavit, G. Wolf, I. Goshen, D. Livshits, and R. Yirmiya Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance Pain 115 2005 50 59
28. N.D. Sternlicht, and Z. Werb Guidebook to the extracellular matrix, anchor, and adhesion proteins Thomas Kreis, Ronald Vale, 1999 Oxford UP New York 503 603
29. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 2001 463 516
30. M. Suzuki, M. Narita, M. Narita, K. Niikura, and T. Suzuki Chronic morphine treatment increases the expression of the neural cell adhesion molecule in the dorsal horn of the mouse spinal cord Neurosci. Lett. 399 2006 202 205
31. Y.H. Tai, Y.H. Wang, R.Y. Tsai, J.J. Wang, P.L. Tao, T.M. Liu, Y.C. Wang, and C.S. Wong Amitriptyline preserves morphine's antinociceptive effect by regulating the glutamate transporter GLAST and GLT-1 trafficking and excitatory amino acids concentration in morphine-tolerant rats Pain 129 2007 343 354
32. N. Takayama, and H. Ueda Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia J. Neurosci. 2 2005 430 435
33. E.L. Way, H.H. Loh, and F.H. Shen Simultaneous quantitative assessment of morphine tolerance and physical dependence J. Pharmacol. Exp. Ther. 167 1969 1 8
34. Z. Werb ECM and cell surface proteolysis: regulating cellular ecology Cell 91 1997 439 442
35. J. Westermarck, and V.M. Kähäri Regulation of matrix metalloproteinase expression in tumor invasion FASEB J. 13 1999 781 792
36. V.W. Yong, C. Power, P. Forsyth, and D.R. Edwards Metalloproteinases in biology and pathology of the nervous system Nat. Rev. Neurosci. 2 2001 502 511